Title
Testing for Euro Dominance in Central and Eastern Europe: An upgrade of the German Dominance Hypothesis,Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 1–3 business days
- Estimated Delivery: 3–5 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
- Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
The Eastern enlargement of the European Union has provided a fresh stimulus to the process of European integration. Ten new member states from Central and Eastern Europe (CEE) will eventually be part of the euro area: Bulgaria, the Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Romania, the Slovak Republic and Slovenia which already adopted the euro. In contrast to previous studies, this monograph treats all transition economies en bloc. Alluding to the wellestablished German Dominance Hypothesis, I formulate the Euro Dominance Hypothesis in a vector error correction model. This framework permits a coherent testing for the presence of monetary integration in Europe and its transmission through financial markets. The findings indicate that the European Central Bank (ECB) influences shortterm interest rates outside the euro area. However, there are crucial feedback relations across the new member states as well as between the transition economies and the ECB. Monetary integration seems to be particularly driven by the emerging banking sectors in CEE.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.